Literature DB >> 26411253

Comparison of modern risk scores in predicting operative mortality for patients undergoing aortic valve replacement for aortic stenosis.

Hironobu Yamaoka1, Kenji Kuwaki2, Hirotaka Inaba1, Taira Yamamoto1, Tomoko S Kato1, Shizuyuki Dohi1, Satoshi Matsushita1, Atsushi Amano1.   

Abstract

BACKGROUND: The aim of our study was to examine and compare the predictive value of operative mortality of the European System for Cardiac Operative Risk Evaluation (EuroSCORE) II, the Society of Thoracic surgeons (STS) score, the Ambler score, and the Japan score in patients undergoing aortic valve replacement (AVR) for aortic stenosis (AS).
METHODS: A total of 406 patients undergoing AVR with or without coronary artery bypass grafting (CABG, n=139) at our institution from August 2002 to December 2013 were enrolled in this cohort study. Accuracy of calibration and discrimination performance of four risk scores was assessed in the overall patient population and quartiles of each risk score.
RESULTS: Operative mortality was 3.4% (n=14). The mean EuroSCORE II, STS score, Ambler score, and the Japan score were 3.1%, 4.9%, 5.7%, and 3.2%, respectively, giving observed-to-expected (O/E) ratio of 1.09, 0.69, 0.59, and 1.06. The C-statistics for operative mortality were 0.704 (EuroSCORE II), 0.781 (STS score), 0.709 (Ambler score), and 0.771 (Japan score). In the last quartile, the EuroSCORE II demonstrated excellent calibration (O/E ratio=0.97) and discrimination (C-statistic=0.904), and the STS score (O/E ratio=0.86, C-statistic=0.779) and the Japan score (O/E ratio=1.14, C-statistic=0.80) showed reasonable correlation. However, the risk calibration by the Ambler score in the last quartile was unacceptable (O/E ratio=0.60).
CONCLUSIONS: The EuroSCORE II and the Japan score showed superior ability of calibration, but the STS score and the Ambler score overestimated the risk. However, the discrimination power was similar among the four risk scores. In the last quartile of risk, the EuroSCORE II gave an excellent predictive performance.
Copyright © 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ambler score; Aortic valve replacement; EuroSCORE II; Japan score; STS score

Mesh:

Year:  2015        PMID: 26411253     DOI: 10.1016/j.jjcc.2015.08.017

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  5 in total

1.  Practice Patterns and Outcomes of Transcatheter Aortic Valve Replacement in the United States and Japan: A Report From Joint Data Harmonization Initiative of STS/ACC TVT and J-TVT.

Authors:  Tsuyoshi Kaneko; Sreekanth Vemulapalli; Shun Kohsaka; Kazuo Shimamura; Amanda Stebbins; Hiraku Kumamaru; Adam J Nelson; Andrzej Kosinski; Koichi Maeda; Joseph E Bavaria; Shigeru Saito; Michael J Reardon; Toru Kuratani; Jeffrey J Popma; Taku Inohara; Vinod H Thourani; John D Carroll; Hideyuki Shimizu; Morimasa Takayama; Martin B Leon; Michael J Mack; Yoshiki Sawa
Journal:  J Am Heart Assoc       Date:  2022-03-04       Impact factor: 6.106

2.  Influence of transcatheter aortic valve replacement on patients with severe aortic stenosis undergoing non-cardiac surgery.

Authors:  Tadashi Omoto; Atsushi Aoki; Kazuto Maruta; Tomoaki Masuda; Yui Horikawa
Journal:  J Cardiothorac Surg       Date:  2020-07-29       Impact factor: 1.637

3.  Transcatheter Aortic Valve Replacement After Coronary Artery Bypass Graft Is Associated With Increased Pacemaker Implantation but Not Reduced Overall Survival.

Authors:  Brent Klinkhammer
Journal:  Cardiol Res       Date:  2018-02-11

4.  Systematic review and meta-analysis of mortality risk prediction models in adult cardiac surgery.

Authors:  Shubhra Sinha; Arnaldo Dimagli; Lauren Dixon; Mario Gaudino; Massimo Caputo; Hunaid A Vohra; Gianni Angelini; Umberto Benedetto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

5.  Mortality risk prediction in high-risk patients undergoing coronary artery bypass grafting: Are traditional risk scores accurate?

Authors:  Maxim Goncharov; Omar Asdrúbal Vilca Mejia; Camila Perez de Souza Arthur; Bianca Maria Maglia Orlandi; Alexandre Sousa; Marco Antônio Praça Oliveira; Fernando Antibas Atik; Rodrigo Coelho Segalote; Marcos Gradim Tiveron; Pedro Gabriel Melo de Barros E Silva; Marcelo Arruda Nakazone; Luiz Augusto Ferreira Lisboa; Luís Alberto Oliveira Dallan; Zhe Zheng; Shengshou Hu; Fabio Biscegli Jatene
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.